GRASSI, GUIDO
 Distribuzione geografica
Continente #
NA - Nord America 93.888
AS - Asia 57.078
EU - Europa 39.867
SA - Sud America 8.011
AF - Africa 1.291
OC - Oceania 154
Continente sconosciuto - Info sul continente non disponibili 74
Totale 200.363
Nazione #
US - Stati Uniti d'America 87.877
SG - Singapore 20.676
CN - Cina 11.067
IT - Italia 8.929
VN - Vietnam 8.556
HK - Hong Kong 8.235
RU - Federazione Russa 6.723
SE - Svezia 6.066
BR - Brasile 6.030
CA - Canada 5.239
DE - Germania 4.349
IE - Irlanda 3.807
UA - Ucraina 2.745
GB - Regno Unito 1.817
FR - Francia 1.783
BD - Bangladesh 1.710
IN - India 1.417
FI - Finlandia 1.042
KR - Corea 896
AR - Argentina 722
TR - Turchia 676
ID - Indonesia 636
IQ - Iraq 557
AT - Austria 507
MX - Messico 435
PK - Pakistan 398
ZA - Sudafrica 397
NL - Olanda 393
JP - Giappone 323
EC - Ecuador 317
ES - Italia 310
PL - Polonia 295
SA - Arabia Saudita 289
PH - Filippine 268
CO - Colombia 248
VE - Venezuela 212
DK - Danimarca 193
UZ - Uzbekistan 188
MY - Malesia 148
CL - Cile 134
MA - Marocco 134
PY - Paraguay 131
AU - Australia 127
TN - Tunisia 123
EG - Egitto 122
KE - Kenya 121
BE - Belgio 118
CZ - Repubblica Ceca 100
AE - Emirati Arabi Uniti 97
PE - Perù 89
TW - Taiwan 89
JO - Giordania 86
TH - Thailandia 83
ET - Etiopia 80
IR - Iran 73
NP - Nepal 72
PT - Portogallo 70
RO - Romania 66
KZ - Kazakistan 64
CH - Svizzera 63
JM - Giamaica 62
LT - Lituania 62
UY - Uruguay 60
AZ - Azerbaigian 59
GR - Grecia 58
DZ - Algeria 57
LB - Libano 54
BO - Bolivia 51
EU - Europa 50
PS - Palestinian Territory 49
AL - Albania 46
BG - Bulgaria 46
NG - Nigeria 45
DO - Repubblica Dominicana 42
OM - Oman 42
IL - Israele 41
SN - Senegal 40
CR - Costa Rica 39
HU - Ungheria 34
PA - Panama 34
KG - Kirghizistan 32
TT - Trinidad e Tobago 32
RS - Serbia 31
HN - Honduras 29
BY - Bielorussia 28
BH - Bahrain 27
NO - Norvegia 27
SK - Slovacchia (Repubblica Slovacca) 23
SY - Repubblica araba siriana 22
BA - Bosnia-Erzegovina 21
LK - Sri Lanka 21
LV - Lettonia 21
NZ - Nuova Zelanda 21
EE - Estonia 20
MU - Mauritius 20
CI - Costa d'Avorio 19
GE - Georgia 19
GT - Guatemala 19
LY - Libia 19
NI - Nicaragua 19
Totale 199.959
Città #
Ann Arbor 12.308
Singapore 10.806
Hong Kong 8.106
Ashburn 6.970
Fairfield 6.266
Woodbridge 6.104
Houston 4.634
San Jose 4.491
Toronto 4.141
Dublin 3.628
Chandler 3.318
Milan 2.981
Wilmington 2.890
Jacksonville 2.851
Seattle 2.624
Ho Chi Minh City 2.553
Frankfurt am Main 2.487
New York 2.342
Hanoi 2.049
Dearborn 2.034
Cambridge 2.015
Stockholm 1.960
Dallas 1.784
Chicago 1.750
Hefei 1.654
Princeton 1.650
Beijing 1.476
Santa Clara 1.438
The Dalles 1.402
Los Angeles 1.267
Lauterbourg 904
Rome 862
Seoul 833
Lawrence 779
Moscow 725
Altamura 724
Nanjing 704
Boardman 663
Buffalo 563
São Paulo 513
Shanghai 503
Council Bluffs 480
Lachine 460
Hangzhou 453
San Diego 435
Helsinki 397
Vienna 377
Jakarta 347
Da Nang 335
Guangzhou 334
Orem 303
Haiphong 281
Andover 277
Munich 277
London 249
Nanchang 243
Baghdad 239
Tokyo 215
Shenyang 210
Salt Lake City 193
Changsha 191
Hebei 191
Dong Ket 189
Rio de Janeiro 187
Ottawa 183
Atlanta 182
Tianjin 180
Warsaw 180
Nuremberg 165
Istanbul 160
Tashkent 160
Brooklyn 155
Chennai 153
Johannesburg 153
Turin 151
Montreal 147
Jiaxing 143
Figino 141
Jinan 141
Falls Church 136
Biên Hòa 131
Phoenix 131
Denver 129
Hải Dương 128
Columbus 126
Norwalk 126
Dhaka 124
Brasília 119
Can Tho 116
Lahore 115
Belo Horizonte 114
Lissone 113
Mumbai 112
Amsterdam 109
Fremont 108
Quito 108
San Francisco 108
Quận Bình Thạnh 107
Ninh Bình 105
Zhengzhou 105
Totale 129.479
Nome #
Behaviour of regional adrenergic outflow in mild-to-moderate renal failure 2.067
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) 859
2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension 632
Dual renin-angiotensin systemblockade and vascular remodeling: Is this a real advantage for vascular protection? 622
Echocardiographic Phenotypes of Subclinical Organ Damage: Clinical and Prognostic Value in the General Population. Findings from the Pamela Study 601
Association Between Atrial, Ventricular and Vascular Morphofunctional Alterations in Rheumatoid Arthritis 542
'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: Morphological criteria and clinical impact 540
Predictors of pwv progression over a three years follow up: focus on psychological characteristics 488
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 487
Sex-related relationships between uric acid and target organ damage in hypertension 485
Myocardial Mechanics in Acromegaly: A Meta-Analysis of Echocardiographic Studies 470
Baroreceptors as a target of device-based neuromodulation in heart failure: Long-term outcomes 461
Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology? 454
Contrasting effects of carotid baroreceptor stimulation on regional sympathetic drive in chronic human heart failure 446
Big data, observational research and P-value: a recipe for false-positive findings? A study of simulated and real prospective cohorts 443
Heart rate as a sympathetic marker during acute adrenergic challenge 433
Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published Studies 420
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 414
Comparison of echotracking and magnetic resonance assessment of abdominal aorta distensibility and relationships with pulse wave velocity 393
Hemodynamic effects of acute and prolonged administration of nitrendipine in essential hypertension 389
Early alterations in left ventricular diastolic function in normotensive diabetic patients 388
Does the 9p region affect arterial stiffness? Results from a cohort of hypertensive individuals 387
Persistence of arterial functional abnormalities after successful coronary revascularization 386
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 384
In healthy normotensive subjects age and blood pressure better predict subclinical vascular and cardiac organ damage than atherosclerosis biomarkers 382
The effects of sex and method of blood pressure measurement on genetic associations with blood pressure in the PAMELA study 378
Calcium antagonists and neural control of circulation in essential hypertension 374
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects 372
A case of Pseudomonas Aeruginosa commercial tattoo infection 369
Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up 365
Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate 365
Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage 365
Differing associations for sport versus occupational physical activity and cardiovascular risk 362
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified 361
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 357
Cardiovascular Remodeling after Endovascular Treatment for Thoracic Aortic Injury 349
Statins and the risk of diabetes: Evidence from a large population-based cohort study 348
Psychological Predictors of Arterial Stiffness Progression over a Three Years Follow Up 348
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 346
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 341
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 336
Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension 332
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension 332
Gender-related differences in serum uric acid in treated hypertensive patients fromcentral and east European countries: Findings from the blood pressure control rate and cardiovascular risk profile study 332
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 332
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 331
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings 329
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 329
Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol 328
Blood pressure response to labetalol in twice and three times daily administration during a 24‐hour period. 326
Cardiopulmonary receptor regulation of renin release 322
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 322
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 321
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: Characteristics and mechanisms 320
Influence of cardiopulmonary receptors on the bradycardiac responses to carotid baroreceptor stimulation in man 319
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 317
Exploring the interplay between job strain and different domains of physical activity on the incidence of coronary heart disease in adult men 317
Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol 315
Historical Archive of Blood Pressure and Evolution of Hypertension 315
Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: A case report 313
Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach 312
The Pamela study: main findings and perspectives 311
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension 311
Pulse wave velocity progressione over a 3.7 years follow-up: focus on metabolic syndrome. 311
Association between uric acid and pulse wave velocity in hypertensive patients and in the general population: a systematic review and meta-analysis 311
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population 311
Prognostic significance of masked tachycardia in hypertension: Evidence from a prospective international registry 309
Cardiovascular risk factor profile in an italian cohort of patients with rheumatoid arthritis: results of a three years follow-up 309
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 308
Heart rate as cardiovascular risk factor 308
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 307
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 307
Left atrial volume in elite athletes: A meta-analysis of echocardiographic studies 306
Neurogenic abnormalities in masked hypertension 305
Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis 305
2007 ESH-ESC guidelines for the management of arterial hypertension - The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC) 304
Similarities and differences between renal sympathetic denervation and carotid baroreceptor stimulation 303
Comparison between non-invasive and invasive pulse wave velocity assessment in human beings 300
Body fat mass is a strong and negative predictor of peak stimulated growth hormone and bone mineral density in healthy adolescents during transition period 299
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 298
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 298
Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis 298
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 297
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: Rationale for further study on blood pressure targets of antihypertensive treatment after stroke 297
Evaluation of a slow-release clonidine preparation by direct continuous blood pressure recording in essential hypertensive patients 296
Modification of arterial baroreflexes by captopril in essential hypertension 295
Vitamin B12 deficiency-induced pseudothrombotic microangiopathy without macrocytosis presenting with acute renal failure: a case report 295
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites 294
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome 293
Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension 293
It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia 293
Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: Results of a double-blind randomized multicentre trial 292
Structural alterations of the retinal microcirculation in the "prehypertensive" high-normal blood pressure state 292
Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients 292
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 292
Baroreflex and non-baroreflex modulation of vagal cardiac control after myocardial infarction 290
Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states 289
Effects of ageing on the cardiopulmonary receptor reflex in normotensive humans 288
Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child a cirrhosis 287
Mechanisms of antihypertensive action of beta-adrenergic blocking drugs: evidence against potentiation of baroreflexes 287
Totale 37.454
Categoria #
all - tutte 673.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 673.561


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210.935 791 951 1.293 930 814 744 526 679 638 762 978 1.829
2022/202314.314 2.112 4.076 1.131 1.153 862 2.360 194 817 889 109 400 211
2023/202411.472 322 293 482 532 1.772 2.742 2.129 325 1.204 226 212 1.233
2024/202531.683 1.760 3.941 1.278 1.366 2.575 926 1.539 1.204 3.523 4.124 3.456 5.991
2025/202680.996 8.086 5.966 5.890 7.638 7.574 3.917 9.810 3.526 5.925 8.153 7.167 7.344
2026/202737 37 0 0 0 0 0 0 0 0 0 0 0
Totale 203.969